{"id":"butazopyridine","rwe":[],"tags":[{"label":"neotropine","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"unknown","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":["butazopyridine"],"offLabel":[],"synonyms":["butazopyridine"],"timeline":[],"ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"neotropine","explanation":"Imagine butazopyridine as a key that unlocks a specific cellular door, allowing the body to heal or function more normally. This process is complex and not fully understood, but it's thought to involve the drug binding to specific proteins or receptors within cells. By doing so, butazopyridine may help to regulate various cellular functions, leading to its therapeutic effects.","oneSentence":"Butazopyridine is thought to work by interacting with cellular processes to produce its therapeutic effects.","technicalDetail":"Butazopyridine's exact mechanism of action is unknown, but it is believed to involve the modulation of cellular signaling pathways, potentially through interactions with neotropine receptors or other molecular targets."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/1898","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=butazopyridine","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T09:05:22.984347","biosimilars":[],"competitors":[],"genericName":"butazopyridine","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"AJ6Z2N6WTI","PUBCHEM_CID":"96213"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","brandName":"butazopyridine","companyName":"","companyId":"unknown","modality":"Small Molecule","firstApprovalDate":"","aiSummary":"Butazopyridine is a small molecule neotropine drug with unknown target and commercial status. Its mechanism of action is not well-documented, and it has not been approved by the FDA for any indications. As a result, there is limited information available on its pharmacokinetics, safety, and efficacy. Further research is needed to fully understand the properties and potential uses of butazopyridine. Its current status as a developmental compound makes it difficult to assess its clinical utility.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}